Dapsone - Revision history

Danbot: Remove disease-specific entries now covered by AntibioticDose (5 sections)

2026-03-20T11:08:34Z

Remove disease-specific entries now covered by AntibioticDose (5 sections)

← Revisión anterior		Revisión del 11:08 20 mar 2026
Línea 5:		Línea 5:

	==Adult Dosing==		==Adult Dosing==
	~~===[[Hansen's disease]] ([[leprosy]])===~~
	*paucibacillary: 100mg PO QD x6mo
	**Use with rifampin
	*multibacillary: 100mg PO QD x12mo
	**Use with rifampin, clofazimine

	~~===[[Bullous pemphigoid]]===~~
	*50mg PO QD
	**Use with topical or systemic [[corticosteroids]]

	~~===Dermatitis herpetiformis===~~
	*50mg PO QD

	~~===[[Malaria]] suppression===~~
	*100mg PO qwk
	**Use with [[pyrimethamine]]
	**Off label use

	~~===[[Toxoplasmosis]] prophylaxis===~~
	*50mg PO QD
	**Off label use

Danbot: Remove disease-specific dosing covered by dynamic SMW tables

2026-03-20T02:58:13Z

Remove disease-specific dosing covered by dynamic SMW tables

← Revisión anterior		Revisión del 02:58 20 mar 2026
Línea 17:		Línea 17:
	===Dermatitis herpetiformis===		===Dermatitis herpetiformis===
	*50mg PO QD		*50mg PO QD

	~~===[[Pneumocystis jirovecii pneumonia\|PCP]]===~~
	*Prophylaxis: 100mg/day PO divided QD-bid
	**Off label use
	*Treatment: 100mg PO QD x21 days
	**Not 1st-line agent; use with [[trimethoprim]]
	**Off label use

	===[[Malaria]] suppression===		===[[Malaria]] suppression===

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:37:53Z

Restore original dosing content alongside dynamic SMW tables

← Revisión anterior		Revisión del 02:37 20 mar 2026
Línea 5:		Línea 5:

	==Adult Dosing==		==Adult Dosing==
			===[[Hansen's disease]] ([[leprosy]])===
			*paucibacillary: 100mg PO QD x6mo
			**Use with rifampin
			*multibacillary: 100mg PO QD x12mo
			**Use with rifampin, clofazimine

			===[[Bullous pemphigoid]]===
			*50mg PO QD
			**Use with topical or systemic [[corticosteroids]]

			===Dermatitis herpetiformis===
			*50mg PO QD

			===[[Pneumocystis jirovecii pneumonia\|PCP]]===
			*Prophylaxis: 100mg/day PO divided QD-bid
			**Off label use
			*Treatment: 100mg PO QD x21 days
			**Not 1st-line agent; use with [[trimethoprim]]
			**Off label use

			===[[Malaria]] suppression===
			*100mg PO qwk
			**Use with [[pyrimethamine]]
			**Off label use

			===[[Toxoplasmosis]] prophylaxis===
			*50mg PO QD
			**Off label use


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Dapsone]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Dapsone]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Dapsone]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Dapsone]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

Danbot: Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

2026-03-20T01:52:48Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

← Revisión anterior		Revisión del 01:52 20 mar 2026
Línea 5:		Línea 5:

	==Adult Dosing==		==Adult Dosing==
	===~~[[Hansen's disease]] ([[leprosy]])~~===		===Indications by Disease===
	*paucibacillary: 100mg PO QD x6mo		{{#ask: [[Has DrugName::Dapsone]] [[Has Population::Adult]]
	**Use with rifampin		\|?Treats disease=Disease
	*multibacillary: ~~100mg PO QD x12mo~~		\|?Has Dose=Dose
	**Use with rifampin, clofazimine		\|?Has Context=Context
			\|format=table
	~~===~~[[~~Bullous pemphigoid~~]]~~===~~		\|limit=50
	*50mg PO QD		\|mainlabel=-
	**Use with topical or systemic [[~~corticosteroids~~]]		\|headers=show
			\|sort=Treats disease
	===~~Dermatitis herpetiformis==~~=		}}
	*50mg PO QD

	~~===[[Pneumocystis jirovecii pneumonia~~\|~~PCP]]==~~=
	*Prophylaxis: 100mg/day PO divided QD-~~bid~~
	**Off label use
	*Treatment: 100mg PO QD x21 days
	**Not 1st-line agent; use with [[trimethoprim]]
	**Off label use

	~~===[[Malaria]] suppression==~~=
	*100mg PO qwk
	**Use with [[pyrimethamine]]
	**Off label use

	=~~==[[Toxoplasmosis]] prophylaxis===~~
	*50mg PO QD
	**Off label use

	==Pediatric Dosing==		==Pediatric Dosing==
			===Indications by Disease===
			{{#ask: [[Has DrugName::Dapsone]] [[Has Population::Pediatric]]
			\|?Treats disease=Disease
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Special Populations==		==Special Populations==

ClaireLewis at 23:51, 20 September 2019

2019-09-20T23:51:01Z

← Revisión anterior		Revisión del 23:51 20 sep 2019
Línea 18:		Línea 18:
	*50mg PO QD		*50mg PO QD

	===PCP===		===[[Pneumocystis jirovecii pneumonia\|PCP]]===
	*Prophylaxis: 100mg/day PO divided QD-bid		*Prophylaxis: 100mg/day PO divided QD-bid
	**Off label use		**Off label use
Línea 81:		Línea 81:

	==References==		==References==
	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:ID]]

Rossdonaldson1 at 13:04, 27 February 2018

2018-02-27T13:04:37Z

← Revisión anterior		Revisión del 13:04 27 feb 2018
Línea 1:		Línea 1:
	==Administration==		==Administration==
	*Type: Antibiotic		*Type: [[Antibiotic]]
	*Dosage Forms: 25,100		*Dosage Forms: 25,100
	*Routes of Administration: Oral		*Routes of Administration: Oral

	==Adult Dosing==		==Adult Dosing==
	*Hansen disease (leprosy)		===[[Hansen's disease]] ([[leprosy]])===
	**paucibacillary: 100mg PO QD x6mo		*paucibacillary: 100mg PO QD x6mo
	***Use with rifampin		**Use with rifampin
	**multibacillary: 100mg PO QD x12mo		*multibacillary: 100mg PO QD x12mo
	***Use with rifampin, clofazimine		**Use with rifampin, clofazimine

	*~~Bullous Pemphigoid:~~ 50mg PO QD		===[[Bullous pemphigoid]]===
	**Use with topical or systemic corticosteroids		*50mg PO QD
			**Use with topical or systemic [[corticosteroids]]

	*Dermatitis herpetiformis: 50mg PO QD		===Dermatitis herpetiformis===
			*50mg PO QD

	*~~PCP prophylaxis~~: 100mg/day PO divided QD-bid		===PCP===
			*Prophylaxis: 100mg/day PO divided QD-bid
	**Off label use		**Off label use
			*Treatment: 100mg PO QD x21 days
	*~~PCP treatment~~: 100mg PO QD x21 days		**Not 1st-line agent; use with [[trimethoprim]]
	**Not 1st-line agent; use with trimethoprim
	**Off label use		**Off label use

	*Malaria suppression: 100mg PO qwk		===[[Malaria]] suppression===
	**Use with pyrimethamine		*100mg PO qwk
			**Use with [[pyrimethamine]]
	**Off label use		**Off label use

	*[[Toxoplasmosis]] prophylaxis: 50mg PO QD		===[[Toxoplasmosis]] prophylaxis===
			*50mg PO QD
	**Off label use		**Off label use

Línea 49:		Línea 53:
	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*anemia, hemolytic		*[[anemia]], hemolytic
	*aplastic anemia		*[[aplastic anemia]]
	*agranulocytosis		*agranulocytosis
	*exfoliative dermatitis		*exfoliative dermatitis
	*erythema multiforme		*[[erythema multiforme]]
	*toxic epidermal necrolysis		*[[toxic epidermal necrolysis]]

	===Common===		===Common===
	*fever		*[[fever]]
	*myalgia		*myalgia
	*headache		*[[headache]]
	*rigors		*rigors
	*fatigue		*fatigue
	*malaise		*malaise
	*dizziness		*[[dizziness]]

	==Pharmacology==		==Pharmacology==

DrKarb: /* Adult Dosing */

2018-02-19T14:51:50Z

Adult Dosing

← Revisión anterior		Revisión del 14:51 19 feb 2018
Línea 10:		Línea 10:
	**multibacillary: 100mg PO QD x12mo		**multibacillary: 100mg PO QD x12mo
	***Use with rifampin, clofazimine		***Use with rifampin, clofazimine

			*Bullous Pemphigoid: 50mg PO QD
			**Use with topical or systemic corticosteroids

	*Dermatitis herpetiformis: 50mg PO QD		*Dermatitis herpetiformis: 50mg PO QD

Mholtz: Text replacement - "qd" to "QD"

2017-07-07T08:59:33Z

Text replacement - "qd" to "QD"

← Revisión anterior		Revisión del 08:59 7 jul 2017
Línea 6:		Línea 6:
	==Adult Dosing==		==Adult Dosing==
	*Hansen disease (leprosy)		*Hansen disease (leprosy)
	**paucibacillary: 100mg PO qd x6mo		**paucibacillary: 100mg PO QD x6mo
	***Use with rifampin		***Use with rifampin
	**multibacillary: 100mg PO qd x12mo		**multibacillary: 100mg PO QD x12mo
	***Use with rifampin, clofazimine		***Use with rifampin, clofazimine

	*Dermatitis herpetiformis: 50mg PO qd		*Dermatitis herpetiformis: 50mg PO QD

	*PCP prophylaxis: 100mg/day PO divided qd-bid		*PCP prophylaxis: 100mg/day PO divided QD-bid
	**Off label use		**Off label use

	*PCP treatment: 100mg PO qd x21 days		*PCP treatment: 100mg PO QD x21 days
	**Not 1st-line agent; use with trimethoprim		**Not 1st-line agent; use with trimethoprim
	**Off label use		**Off label use
Línea 24:		Línea 24:
	**Off label use		**Off label use

	*[[Toxoplasmosis]] prophylaxis: 50mg PO qd		*[[Toxoplasmosis]] prophylaxis: 50mg PO QD
	**Off label use		**Off label use

ClaireLewis: /* Adult Dosing */

2016-09-29T02:58:19Z

Adult Dosing

← Revisión anterior		Revisión del 02:58 29 sep 2016
Línea 16:		Línea 16:
	**Off label use		**Off label use

	*PCP tx: 100mg PO qd x21 days		*PCP treatment: 100mg PO qd x21 days
	**Not 1st-line agent; use with trimethoprim		**Not 1st-line agent; use with trimethoprim
	**Off label use		**Off label use

Neil.m.young: Text replacement - "0 mg" to "0mg"

2016-07-21T11:25:08Z

Text replacement - "0 mg" to "0mg"

← Revisión anterior		Revisión del 11:25 21 jul 2016
Línea 6:		Línea 6:
	==Adult Dosing==		==Adult Dosing==
	*Hansen disease (leprosy)		*Hansen disease (leprosy)
	**paucibacillary: ~~100 mg~~ PO qd x6mo		**paucibacillary: 100mg PO qd x6mo
	***Use with rifampin		***Use with rifampin
	**multibacillary: ~~100 mg~~ PO qd x12mo		**multibacillary: 100mg PO qd x12mo
	***Use with rifampin, clofazimine		***Use with rifampin, clofazimine

	*Dermatitis herpetiformis: ~~50 mg~~ PO qd		*Dermatitis herpetiformis: 50mg PO qd

	*PCP prophylaxis: ~~100 mg~~/day PO divided qd-bid		*PCP prophylaxis: 100mg/day PO divided qd-bid
	**Off label use		**Off label use

	*PCP tx: ~~100 mg~~ PO qd x21 days		*PCP tx: 100mg PO qd x21 days
	**Not 1st-line agent; use with trimethoprim		**Not 1st-line agent; use with trimethoprim
	**Off label use		**Off label use

	*Malaria suppression: ~~100 mg~~ PO qwk		*Malaria suppression: 100mg PO qwk
	**Use with pyrimethamine		**Use with pyrimethamine
	**Off label use		**Off label use

	*[[Toxoplasmosis]] prophylaxis: ~~50 mg~~ PO qd		*[[Toxoplasmosis]] prophylaxis: 50mg PO qd
	**Off label use		**Off label use